Website News and Research

RSS

Vivakor launches new website to promote its remarkable VivaThermic Vial

Vivakor, Inc. today announced the launch of its new website promoting its remarkable VivaThermic Vial at www.vivathermic.com.

14 Dec 2009

At the Crossroads: A guide to Alzheimer’s disease, dementia and driving

Every 70 seconds, someone develops Alzheimer’s disease.¹ In conjunction with National Older Driver Safety Awareness Week, Dec. 6-12, leading researchers are joining forces to encourage families to talk openly with loved ones about driving as soon as they are diagnosed with a form of dementia.

14 Dec 2009

Autism research at The Children's Hospital of Philadelphia named among top ten medical breakthroughs

Autism research led by scientists at The Children's Hospital of Philadelphia has been named one of the top ten medical breakthroughs of 2009 by Time Magazine.

14 Dec 2009

Positive interim results of ARRY-380 in Phase 1 trial announced

Array BioPharma Inc. today announced positive interim results of its novel, small molecule HER2 (ErbB2) inhibitor, ARRY-380, in a Phase 1 trial in advanced cancer patients.

13 Dec 2009

PURE Bioscience reports revenues for fiscal quarter ended October 31, 2009

PURE Bioscience, creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today reported revenues for the fiscal quarter ended October 31, 2009 of $221,900 compared with revenues of $110,600 in the same quarter of the prior fiscal year.

12 Dec 2009

BaylorHealth.com wins gold at Healthcare Internet Conference and silver at W3 Awards

Baylor Health Care System's website - BaylorHealth.com - took home the gold at the thirteenth annual Healthcare Internet Conference and silver at this year's W3 Awards.

11 Dec 2009

Zevalin clinical data presented at 2009 ASH meeting

Spectrum Pharmaceuticals, Inc., a commercial stage biotechnology company with a primary focus in oncology, today announced that clinical data on ZEVALIN (ibritumomab tiuxetan) was presented at the 51st Annual Meeting of the American Society of Hematology (ASH), which was held December 5-8, 2009 at the Ernest N. Morial Convention Center in New Orleans, Louisiana.

11 Dec 2009

"Gift a bed net" initiative to prevent malaria

Along with the joy of the holiday season comes the usual pressure for families. There are cards to send, cookies to bake, and gifts to wrap. However, one thing most American families don't have to worry this Christmas is finding enough money to protect their children from a life-threatening illness. That's not the case for families like Rachell Chuya and her five children in Zambia.

11 Dec 2009

"Checklists" for evaluating comparative effectiveness research

A new report released today by the National Pharmaceutical Council (NPC) provides guidance in the evaluation of comparative effectiveness research (CER), including easy-to-use "checklists" that help make sure such studies can be used to improve the dialogue between health care providers and patients, as well as better inform health care decision-making.

11 Dec 2009

Update on proposed transaction that will lead to the merger of Cytopia into YM BioSciences provided

YM BioSciences Inc., a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various stages of development, today provided an update on the proposed transaction which would result in the merger of Cytopia Ltd. into YM, details of which were announced on October 5, 2009.

11 Dec 2009

McGraw-Hill Education's free instructional resources on H1N1 available online

When H1N1 or other illnesses prevent school attendance, students, parents and teachers can now access a variety of McGraw-Hill Education's free instructional resources on the web.

11 Dec 2009

Perspective on HIPAA 5010 and ICD-10 testing presented by Edifecs

Edifecs, Inc., the proven leader in HIPAA 5010 and Healthcare Channel Modernization solutions, announced today that Sunny Singh, Edifecs CEO, was invited by the NCVHS (National Committee for Vital and Health Statistics) to present his perspective regarding HIPAA 5010 and ICD-10 testing.

11 Dec 2009

Public health information website to provide information about advanced disinfectants launched

TouchSurfaces.Org launches a public health information website alerting visitors on how the hard surfaces in the home, the work place, and in public venues can act as host to a multitude of infectious viruses and bacteria including H1N1, MRSA, HIV, and others.

10 Dec 2009

Biomonitoring expert to comment on upcoming CDC report

An expert specializing in communications to the general public on the scientific techniques for assessing and interpreting the significance of human exposure to natural and synthetic chemicals is available to provide comment and analysis on the upcoming report on biomonitoring by the Centers for Disease Control and Prevention (CDC).

10 Dec 2009

Phase 3 clinical trial results of RG1068 to be discussed

Repligen Corporation announced today that the Company President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will host a conference call and webcast on Wednesday, December 9th, 2009 at 8:30 a.m. EST, to discuss results of its Phase 3 clinical trial of RG1068 in MRI imaging of the pancreas.

9 Dec 2009

Neoprobe completes Phase 3 Lymphoseek clinical trial on breast cancer patients

Neoprobe Corporation (OTCBB: NEOP), a diversified developer of innovative oncology surgical and diagnostic products, has completed a Phase 3 clinical trial of Lymphoseek® (NEO3-05) with positive results.

9 Dec 2009

CSL Behring selects BioRx as an approved Berinert provider

BioRx, a specialty pharmacy company, has been named one of a small number of approved providers of Berinert®. Berinert® is a plasma-derived concentrate of C1 esterase inhibitor (human) indicated for the treatment of acute abdominal or facial attacks of hereditary angioedema (HAE) in adult and adolescent patients. CSL Behring, the manufacturer of Berinert® selected BioRx as part of their distribution network to launch this exciting new product in the United States.

8 Dec 2009

Seattle-based Qualis Health selects Genuine Interactive as its interactive agency of record

Qualis Health names Genuine Interactive as its interactive agency of record, according to John Grayson, president of the interactive marketing agency (http://www.genuineinteractive.com). The Seattle-based Qualis Health chose Genuine Interactive after a national review of firms.

8 Dec 2009

Pixantrone demonstrates substantial reduction in cardiac cell toxicity compared to anthracyclines

Cell Therapeutics, Inc. announced today an abstract to be published online at the journal Blood website by M. Hacker, et al. demonstrating significant reduction in cardiac cell toxicity with pixantrone compared to currently marketed anthracyclines. The authors conclude that the reduction is due to pixantrone's inability to generate toxic drug iron complexes and reduced propensity to generate oxygen free radicals.

8 Dec 2009

Workforce Alliance receives $134,790 grant to fund workforce training program

Workforce Alliance was awarded a $134,790 grant by the State of Florida to fund a workforce training program aimed at meeting the high need for skilled health care workers in Palm Beach County.

8 Dec 2009